The MDM4/MDM2-p53-IGF1 axis controls axonal regeneration, sprouting and functional recovery after CNS injury

Yashashree Joshi1, Marília Grando Sória2, Giorgia Quadrato3

  • 11 Laboratory for NeuroRegeneration and Repair, Centre for Neurology, Hertie Institute for Clinical Brain Research, University of Tuebingen, Tuebingen, Germany 2 Graduate School for Cellular and Molecular Neuroscience, University of Tuebingen, Tuebingen, Germany 3 German Centre for Neurodegenerative Diseases (DZNE), Tuebingen, Germany.

Insights

Researchers identified a molecular pathway involving MDM4, MDM2, p53, and IGF1R that restricts central nervous system (CNS) axon regeneration. Inhibiting this pathway promotes axonal regrowth and functional recovery after CNS injury.

Area of Science:

  • Neuroscience
  • Molecular Biology
  • Regenerative Medicine

Background:

  • Central nervous system (CNS) axon regeneration is limited after injury, leading to persistent neurological deficits.
  • The molecular mechanisms governing CNS regenerative potential remain incompletely understood.
  • Ubiquitin ligases are known regulators of neuronal development and response to injury, but their role in axonal regeneration is unexplored.

Purpose of the Study:

  • To identify novel molecular regulators of CNS axonal regeneration.
  • To investigate the role of ubiquitin ligases in the regenerative response after CNS injury.
  • To explore therapeutic targets for enhancing neurological recovery.

Main Methods:

  • Bioinformatics network analysis to identify potential signaling complexes.
  • Conditional gene deletion (MDM4, p53) in mouse models.
  • Pharmacological inhibition of protein-protein interactions (MDM2/p53).
  • Axonal regeneration assays in optic nerve and spinal cord injury models.
  • Genome-wide gene expression analysis (RNA-seq) and fluorescence-activated cell sorting (FACS).
  • Functional recovery assessments after spinal cord injury.

Main Results:

  • A signaling triad of MDM4, MDM2, and p53 was identified as a negative regulator of CNS regeneration.
  • Conditional deletion of MDM4 or inhibition of MDM2/p53 interaction promoted axonal regeneration and sprouting.
  • Regeneration was dependent on p53, and IGF1R was identified as a key downstream target.
  • Pharmacological enhancement of the MDM2/p53-IGF1R axis improved axonal sprouting and functional recovery post-spinal cord injury.

Conclusions:

  • The MDM4-MDM2/p53-IGF1R axis represents a novel regulatory mechanism restricting CNS regeneration.
  • Targeting this pathway offers a promising therapeutic strategy for promoting axonal regrowth and functional recovery after CNS injuries.
  • This discovery opens new avenues for developing treatments for neurological impairments.